Patient Guide: SURPASS-3: Tirzepatide vs Tresiba in adults with type 2 diabetes inadequately controlled on metformin with or without SGLT2i (52 weeks, open-label, active-controlled, phase 3)

We'll Help You Connect with This Trial

Quri.ai is a free clinical trial matching service. We help patients like you connect directly with research sites conducting this study.

  • Get matched to the right study location for you
  • Connect directly with study coordinators at multiple participating sites
  • Understand eligibility with our simplified screening tool
  • Free service - we're here to help you access clinical research
Trial ID: NCTSURPASS-3
Status: COMPLETED
Condition: Type 2 diabetes mellitus
Phase: PHASE3

Loading interactive enrollment tools...

The full interactive experience will load momentarily